OBJECTIVE: To investigate whether ethnic differences exist in the effect of the shared epitope and selected cytokine gene polymorphisms on the susceptibility and severity of rheumatoid arthritis in Syria (Damascus) and France (Rhône-Alpes area). METHODS: 156 patients with rheumatoid arthritis and 120 healthy controls from Syria were compared with 512 patients with rheumatoid arthritis and 471 healthy controls from France. Shared epitope status, cytokine gene polymorphisms interleukin (IL)-1B +3954, IL-1RN +2018 and tumour necrosis factor alpha promoter (-238 and -308) were analysed by enzyme-linked oligosorbent assay. Joint destruction was defined by a right wrist Larsen score > or =2. Odds ratios (ORs) were calculated. RESULTS: In both countries, a dose effect was observed between the shared epitope copy number and rheumatoid arthritis (Syria: OR 1 v 0 copies = 1.6, p = NS; OR 2 v 0 = 15.3, p<0.01; and France: OR 1 v 0 = 2.3, p<0.001; OR 2 v 0 = 7.2, p<0.001). A dose effect was also observed between the shared epitope copy number and joint destruction in Syria (OR 1 v 0 = 2.2, p = NS; OR 2 v 0 = 9.9, p<0.01) and France (OR 1 v 0 = 1.8, p<0.01; OR 2 v 0 = 4.8, p = 0.001). The dose effect of the shared epitope was greater in Syria than in France. Only the -238 tumour necrosis factor alpha polymorphism was associated with joint destruction in the Syrian population (p<0.05). However, after adjustment for age, sex, disease duration and rheumatoid factor for severity, this association disappeared. CONCLUSION: The frequency of the shared epitope was increased in the French population with rheumatoid arthritis and in controls, but the association between the shared epitope and joint destruction was more pronounced in the Syrian population, with an OR of almost 10 for the homozygotes.
OBJECTIVE: To investigate whether ethnic differences exist in the effect of the shared epitope and selected cytokine gene polymorphisms on the susceptibility and severity of rheumatoid arthritis in Syria (Damascus) and France (Rhône-Alpes area). METHODS: 156 patients with rheumatoid arthritis and 120 healthy controls from Syria were compared with 512 patients with rheumatoid arthritis and 471 healthy controls from France. Shared epitope status, cytokine gene polymorphisms interleukin (IL)-1B +3954, IL-1RN +2018 and tumour necrosis factor alpha promoter (-238 and -308) were analysed by enzyme-linked oligosorbent assay. Joint destruction was defined by a right wrist Larsen score > or =2. Odds ratios (ORs) were calculated. RESULTS: In both countries, a dose effect was observed between the shared epitope copy number and rheumatoid arthritis (Syria: OR 1 v 0 copies = 1.6, p = NS; OR 2 v 0 = 15.3, p<0.01; and France: OR 1 v 0 = 2.3, p<0.001; OR 2 v 0 = 7.2, p<0.001). A dose effect was also observed between the shared epitope copy number and joint destruction in Syria (OR 1 v 0 = 2.2, p = NS; OR 2 v 0 = 9.9, p<0.01) and France (OR 1 v 0 = 1.8, p<0.01; OR 2 v 0 = 4.8, p = 0.001). The dose effect of the shared epitope was greater in Syria than in France. Only the -238 tumour necrosis factor alpha polymorphism was associated with joint destruction in the Syrian population (p<0.05). However, after adjustment for age, sex, disease duration and rheumatoid factor for severity, this association disappeared. CONCLUSION: The frequency of the shared epitope was increased in the French population with rheumatoid arthritis and in controls, but the association between the shared epitope and joint destruction was more pronounced in the Syrian population, with an OR of almost 10 for the homozygotes.
Authors: Martina Fabris; Emma Di Poi; Angela D'Elia; Giuseppe Damante; Luigi Sinigaglia; Gianfranco Ferraccioli Journal: J Rheumatol Date: 2002-01 Impact factor: 4.666
Authors: D Jawaheer; M F Seldin; C I Amos; W V Chen; R Shigeta; J Monteiro; M Kern; L A Criswell; S Albani; J L Nelson; D O Clegg; R Pope; H W Schroeder ; S L Bridges ; D S Pisetsky; R Ward; D L Kastner; R L Wilder; T Pincus; L F Callahan; D Flemming; M H Wener; P K Gregersen Journal: Am J Hum Genet Date: 2001-03-09 Impact factor: 11.025
Authors: A Balsa; N J Minaur; D Pascual-Salcedo; C McCabe; A Balas; B Fiddament; J L Vicario; N L Cox; E Martín-Mola; N D Hall Journal: Rheumatology (Oxford) Date: 2000-08 Impact factor: 7.580
Authors: N Buchs; T Silvestri; F S di Giovine; M Chabaud; E Vannier; G W Duff; P Miossec Journal: Rheumatology (Oxford) Date: 2000-10 Impact factor: 7.580
Authors: F Cornélis; S Fauré; M Martinez; J F Prud'homme; P Fritz; C Dib; H Alves; P Barrera; N de Vries; A Balsa; D Pascual-Salcedo; K Maenaut; R Westhovens; P Migliorini; T H Tran; A Delaye; N Prince; C Lefevre; G Thomas; M Poirier; S Soubigou; O Alibert; S Lasbleiz; S Fouix; C Bouchier; F Lioté; M N Loste; V Lepage; D Charron; G Gyapay; A Lopes-Vaz; D Kuntz; T Bardin; J Weissenbach Journal: Proc Natl Acad Sci U S A Date: 1998-09-01 Impact factor: 11.205
Authors: Yukinori Okada; Kwangwoo Kim; Buhm Han; Nisha E Pillai; Rick T-H Ong; Woei-Yuh Saw; Ma Luo; Lei Jiang; Jian Yin; So-Young Bang; Hye-Soon Lee; Matthew A Brown; Sang-Cheol Bae; Huji Xu; Yik-Ying Teo; Paul I W de Bakker; Soumya Raychaudhuri Journal: Hum Mol Genet Date: 2014-07-28 Impact factor: 6.150
Authors: Erik J M Toonen; Pilar Barrera; Jaap Fransen; Arjan P M de Brouwer; Agnes M Eijsbouts; Pierre Miossec; Hubert Marotte; Hans Scheffer; Piet L C M van Riel; Barbara Franke; Marieke J H Coenen Journal: Arthritis Res Ther Date: 2012-12-07 Impact factor: 5.156
Authors: Yukinori Okada; Dorothee Diogo; Jeffrey D Greenberg; Faten Mouassess; Walid A L Achkar; Robert S Fulton; Joshua C Denny; Namrata Gupta; Daniel Mirel; Stacy Gabriel; Gang Li; Joel M Kremer; Dimitrios A Pappas; Robert J Carroll; Anne E Eyler; Gosia Trynka; Eli A Stahl; Jing Cui; Richa Saxena; Marieke J H Coenen; Henk-Jan Guchelaar; Tom W J Huizinga; Philippe Dieudé; Xavier Mariette; Anne Barton; Helena Canhão; João E Fonseca; Niek de Vries; Paul P Tak; Larry W Moreland; S Louis Bridges; Corinne Miceli-Richard; Hyon K Choi; Yoichiro Kamatani; Pilar Galan; Mark Lathrop; Towfique Raj; Philip L De Jager; Soumya Raychaudhuri; Jane Worthington; Leonid Padyukov; Lars Klareskog; Katherine A Siminovitch; Peter K Gregersen; Elaine R Mardis; Thurayya Arayssi; Layla A Kazkaz; Robert M Plenge Journal: PLoS One Date: 2014-02-10 Impact factor: 3.240